Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago global QSR franchisor (NYSE: MCD) $25.7B FY2024 revenue; 40K locations, 95%+ franchised, 175M loyalty app users, E. coli Q4 2024 recovery, McValue 2025 competing with Burger King and Yum!.
McDonald's Corporation is a Chicago, Illinois-based global fast food restaurant operator and franchisor — publicly traded on the New York Stock Exchange (NYSE: MCD) as a Dow Jones Industrial Average and S&P 500 Consumer Discretionary component — operating approximately 40,000 restaurants in 100+ countries through a predominantly franchised model (95%+ franchised) where independent operators pay royalties and rent for the McDonald's brand, systems, and real estate, generating restaurant revenues for franchisees and fee-based revenues for McDonald's Corporation. In fiscal year 2024, McDonald's reported revenues of $25.7 billion (comprised of franchisee royalty and rental income plus company-operated restaurant sales), with comparable sales declining 1.5% globally for the year as value-seeking consumer behavior and a significant E. coli outbreak (October 2024, Quarter Pounder onion contamination — affecting 104 people across multiple states, causing one death) weighed on traffic in Q4 2024. CEO Chris Kempczinski's strategy focuses on the "Accelerating the Arches" growth framework: marketing investment in core menu items (Big Mac, McChicken, McNuggets, fries), digital ordering acceleration (McDonald's mobile app surpassing 175 million 90-day active users globally by 2024), loyalty program expansion (MyMcDonald's Rewards — generating over $20 billion in annual system-wide loyalty sales), and value platform restoration (McValue menu launch in 2025 restoring affordable entry-price items that franchise operators had reduced during inflation-driven menu price increases).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.